In one study, an autocrine and paracrine mode of action for VASH2 was found to enhance the expression of FGF-2 and VEGF by nuclear factor-κB upregulation in hepatocellular carcinoma (HCC) cells (11). The gene discussed is VASH2; the disease is hepatocellular carcinoma.